New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADBE;ALXA;BBY;BV;ZQK;CYTX From The Last 14 Days
Check below for free stories on ADBE;ALXA;BBY;BV;ZQK;CYTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
09:07 EDTCYTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTCYTXBARDA executes contract option with Cytori valued at $12.1M
Subscribe for More Information
August 18, 2014
13:31 EDTCYTXCytori Therapeutics appoints Girao CFO to replace Saad
Subscribe for More Information
August 14, 2014
09:05 EDTALXAAlexza Pharmaceuticals updates five post-EMA approval studies for Adasuve
Subscribe for More Information
August 12, 2014
11:20 EDTCYTXCytori Therapeutics reports publication of six month data from scleroderma study
Cytori Therapeutics (NASDAQ: CYTX) today announced that six month outcomes from a 12 patient independent investigator-initiated study using Cytori Cell Therapy to treat scleroderma have been published in the Annals of Rheumatic Disease. Data from the study indicated that treatment with Cytori Cell Therapy was safe and well tolerated through six months. In addition, the data indicated an approximately 50% average improvement across four key, validated endpoints used to assess the clinical status in patients with systemic scleroderma with impaired hand function at two months, with benefits sustained through six month follow-up. “After six month follow up, we are encouraged by the results that have been seen by the investigators in France...The investigators in Marseille have continued to follow the patients and are considering a larger, controlled study based on these positive outcomes,” said Dr. Steven Kesten, Chief Medical Officer, Cytori.
08:03 EDTBBYGoldman's Retail selections for Q2
Goldman is most above Q2 consensus for Advance Auto Parts (AAP), Best Buy (BBY) and Williams-Sonoma (WSM), sees best risk/reward in Ulta Salon (ULTA) and Sportsman's Warehouse (SPWH), and low visibility in Dick's Sporting (DKS) and Wal-Mart (WMT).
August 11, 2014
16:21 EDTCYTXCytori Therapeutics announces departure of CFO Mark Saad
Cytori Therapeutics announced that Mark Saad, its CFO, has accepted a new opportunity and will be officially leaving Cytori, effective today. It added, "Cytori has recruited a highly qualified candidate who is extremely familiar with Cytori and is currently employed at a local medical company to be our next CFO and VP Finance. The Company will provide a further update on the CFO candidate, who is anticipated to start in September, on the investor call this afternoon." The board has appointed Dr. Marc Hedrick, Cytori’s CEO, to serve as Principal Financial Officer until a new CFO is appointed.
16:19 EDTCYTXCytori Therapeutics reports Q2 EPS (15c), consensus (13c)
Subscribe for More Information
August 10, 2014
16:51 EDTADBECourt rejects $324M settlement in tech hiring conspiracy, NYT says
Subscribe for More Information
August 8, 2014
16:16 EDTADBEU.S. judge rejects Apple, Google antitrust hiring accord, Bloomberg reports
Subscribe for More Information
13:57 EDTZQKInvesco reports 11.7% passive stake in Quiksilver
Subscribe for More Information
10:00 EDTALXAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:01 EDTALXAAlexza Pharmaceuticals announces launch of ADASUVE
Subscribe for More Information
06:38 EDTALXAAlexza Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information
August 7, 2014
16:44 EDTALXAAlexza Pharmaceuticals reports Q2 EPS (34c), consensus (67c)
Reports Q2 revenue $1.5M, consensus $2.24M.
August 6, 2014
12:50 EDTBBYBest Buy volatility flat into Q2 and revenue outlook
Subscribe for More Information
10:00 EDTCYTXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:13 EDTCYTXOn The Fly: Pre-market Movers
HIGHER: Fox class A shares (FOXA), up 5.9% after withdrawing proposal to acquire Time Warner (TWX), announcing $6B share repurchase program, reporting quarterly results... MannKind (MNKD), up 1.6% after entering a supply agreement with Amphastar Pharmaceuticals (AMPH)... Criteo (CRTO), up 11.5% after upgraded at Goldman following its better than expected Q2 earnings report. LOWER: Time Warner (TWX), down 13% after earnings, maintaining guidance, bid dropped by Fox... Sprint (S), down 16.5% after naming Marcelo Claure as president and CEO, reportedly dropping pursuit of T-Mobile (TMUS). T-Mobile shares also down 8.5%... Groupon (GRPN), down 18%, downgraded at Wunderlich after the company reported lower than expected Q3 results... Walgreen (WAG), down 15.7% after exercises option to acquire remaining 55% of Alliance Boots, says it will not pursue inversion as part of deal... Shire (SHPG), down 6% after Walgreen announced it would stay located in Chicago and Bloomberg last night reported that the Treasury Department is exploring ways to bypass Congress in an attempt to curb corporate inversions... Cytori Therapeutics (CYTX), down 33% after announcing that it has placed enrollment in the ATHENA and ATHENA II trials on clinical hold. UP AFTER EARNINGS: Enphase Energy (ENPH), up 20%... AOL (AOL), up 5%. DOWN AFTER EARNINGS: Nu Skin (NUS), down 8.5%... Rocket Fuel (FUEL), down 27%... Cognizant (CTSH), down 13%... First Solar (FSLR), down 2.5%... Globus Medical (GMED), down 17%.
08:38 EDTCYTXCytori Therapeutics downgraded to Hold from Buy at Ascendiant
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use